Josep M. Llovet
0000-0003-0547-2667
Publication & Citation Trends
Publications
0 total
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma
Cited by 0
Semantic Scholar
Molecular insights into early malignant transition of hepatocellular carcinoma
Cited by 0
Semantic Scholar
SAT-113 The intratumoral microbiome in HCC and its impact on treatment response
Cited by 0
Semantic Scholar
THU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma
Cited by 1
Semantic Scholar
LBP-029-YI Spatial transcriptomics of the tumor microenvironment discriminates inflamed tumors responsive or resistant to atezolizumab + bevacizumab in patients with advanced HCC
Cited by 0
Semantic Scholar
TOP-128-YI Efficacy of WNTinib, a novel selective therapeutic for CTNNB1mutant tumors, in preclinical models of hepatoblastoma
Cited by 0
Semantic Scholar
SAT-086 Tumour-infiltrating regulatory T cells engage Nrf2 signalling to support their metabolic adaptation in hepatocellular carcinoma
Cited by 0
Semantic Scholar
THU-078 Artificial intelligence-driven prediction of biology-related poor outcome and presence of vascular invasion in hepatocellular carcinoma
Cited by 0
Semantic Scholar
Research Topics
Hepatocellular Carcinoma Treatment and Prognosis
(400)
Liver Disease Diagnosis and Treatment
(224)
Hepatitis B Virus Studies
(93)
Cancer, Lipids, and Metabolism
(80)
Ferroptosis and cancer prognosis
(76)
Affiliations
Nihon University
University of Pisa
Goethe University Frankfurt
Institució Catalana de Recerca i Estudis Avançats
Mount Sinai Hospital